Ignite Creation Date:
2024-05-05 @ 5:09 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00398567
Status:
COMPLETED
Last Update Posted:
2018-07-24
First Post:
2006-11-09
Brief Title:
A Phase 12 Study Of HKI-272 Neratinib in Combination With Trastuzumab Herceptin In Subjects With Advanced Breast Cancer
Sponsor:
Puma Biotechnology Inc
Organization:
Puma Biotechnology Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-04-04
Start Date Type:
ACTUAL
Primary Completion Date:
2009-07-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-03-02
Completion Date Type:
ACTUAL
First Submit Date:
2006-11-09
First Submit QC Date:
November 9 2006
Study First Post Date:
2006-11-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2018-04-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2011-02-25
Disp First Submit QC Date:
February 25 2011
Disp First Post Date:
2011-03-11
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2018-06-26
Last Update Post Date:
2018-07-24
Last Update Post Date Type:
ACTUAL